Supply Chain | February 26, 2025
Amgen India investment totals $200 million through 2025
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
The USFDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated
Subscribe To Our Newsletter & Stay Updated
